XML 66 R40.htm IDEA: XBRL DOCUMENT v2.4.1.9
Fair Value of Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Fair Value of Gross Position of Derivative Contracts in Consolidated Balance Sheets

The following table presents the location and amounts of derivative instrument fair values in the Consolidated Balance Sheets:

 

     Year ended December 31  
Assets/(Liabilities)    2013     2014  

Designated as hedging instruments:

    

Gross amounts recognized

   $ 2,702      $ 6,483   

Gross amounts offset

     (2,232     (504
  

 

 

   

 

 

 

Net amounts

     470        5,979   

Not designated as hedging instruments:

    

Gross amounts recognized

     (121     —     

Gross amounts offset

     —          —     
  

 

 

   

 

 

 

Net amounts

     (121     —     
  

 

 

   

 

 

 

Other current assets

   $ 349      $ 5,979   
  

 

 

   

 

 

 
Gains and Losses on Derivative Instruments in Consolidated Statement of Operations

The following table presents the location and amount of gains and losses on derivative instruments in the Consolidated Statements of Income:

 

Derivatives Designated as Cash Flow Hedges

   Amount of Gain (Loss)
Recognized in
Other Comprehensive
Income on Derivative
(Effective Portion)
     Amount of Gain
Reclassified
from Cumulative
Other Comprehensive
Loss into Income
(Effective Portion)
     Amount of Gain (Loss)
Recognized in
Income
on Derivative
(Ineffective Portion)
 

Year ended Dec. 31, 2012

   $ (1,770 )    $ 5,699       $ 256   

Year ended Dec. 31, 2013

   $ 2,943      $ 1,085       $ (122

Year ended Dec. 31, 2014

   $ 9,020      $ 3,699       $ (188

 

Derivatives not Designated as Hedging Instruments

 

Location of Gain (Loss)

Recognized in Income

on Derivatives

   Amount of Gain (Loss)
Recognized in Income
on Derivatives
 

Year ended Dec. 31, 2012

  Other income (expense)    $ 590   

Year ended Dec. 31, 2013

  Other income (expense)    $ (366

Year ended Dec. 31, 2014

  Other income (expense)    $ 121   

 

Assets and Liabilities Measured at Fair Value on Recurring Basis

The following table presents the Company’s fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis as of December 31, 2013 and 2014:

 

                                                                                                                                   
     December 31, 2013  
     Total
Assets
(Liabilities)
     Quoted Prices
in Active Markets
for Identical
Assets
Level (1)
     Significant
Other
Observable
Inputs
Level (2)
     Significant
Unobservable
Inputs
Level (3)
 

Foreign Exchange Contracts

   $ 349       $ —         $ 349       $ —     

Stock-based Liabilities

   $ (12,462    $ (12,462    $ —         $ —     

 

                                                                                                                                   
     December 31, 2014  
     Total
Assets
(Liabilities)
     Quoted Prices
in Active Markets
for Identical
Assets

Level (1)
     Significant
Other
Observable
Inputs
Level (2)
     Significant
Unobservable
Inputs

Level (3)
 

Foreign Exchange Contracts

   $ 5,979       $ —         $ 5,979       $ —     

Stock-based Liabilities

   $ (19,079    $ (19,079    $ —         $ —     

 

Movement in the Level 3 Fair Value Measurements

The following table presents the movement in the Level 3 fair value measurements for the year ended December 31, 2014.

 

     Fair Value Measurements Using Significant
Unobservable Inputs (Level 3)
 
     Redeemable noncontrolling shareholder interest  
     Year Ended
December 31, 2014
 

Beginning Balance

   $ —     

Transfer into Level 3 - Redeemable noncontrolling shareholder interest

     (152,250 )

Adjustment for CCT valuation amount

     (956 )

Sale of interest in subsidiary

     153,206  
  

 

 

 

Ending Balance

$ —     
  

 

 

Carrying Amounts and Fair Values of Financial Instruments
The carrying amounts and fair values of the Company’s financial instruments were as follows:

 

     December 31, 2013      December 31, 2014  
     Carrying
Amount
     Fair Value
Measurements
Using Quoted
Prices in Active
Markets for
Identical
Instruments
Level (1)
     Carrying
Amount
     Fair Value
Measurements
Using Quoted
Prices in Active
Markets for
Identical
Instruments
Level (1)
 

Cash and cash equivalents

   $ 397,731       $ 397,731       $ 551,652       $ 551,652   

Notes receivable

     86,965         86,965         4,546         4,546   

Restricted cash

     2,759         2,759         653         653   

Notes payable

     (22,105      (22,105      (64,551      (64,551

Current portion of long-term debt

     (17,868      (17,868      (2,115      (2,115

Long-term debt

     (320,959      (334,759      (298,931      (325,431